Pharmafile Logo

News and Press Releases

Revolutionising Patient Care: ProPharma and PBL Launch Innovative Cell & Gene Therapy Manufacturing Device

First-of-its-kind Cell Factory Box streamlines production, making advanced treatments accessible and affordable 2 May 2024 -- Raleigh, North Carolina -- ProPharma, the leading global provider of regulatory, clinical and compliance services...

Category: BioManufacturing, Clinical Trials, Drug Discovery
Posted: May 2, 2024

ProPharma
107 West Hargett St. Raleigh, NC 27601

Asahi Kasei Bioprocess to Unveil THESYS ACS ERGO Synthesis Column at TIDES USA – offering reduced changeover time while maintaining safety and product quality

30 April 2024 -- Düsseldorf, Germany; Tokyo, Japan; and New York, US -- Generating cutting-edge therapeutics requires precision, safety and efficiency from manufacturing equipment. The next generation of oligo manufacturing,...

Category: BioManufacturing, Manufacturing and Packing
Posted: April 30, 2024

Asahi Kasei
1-1-2 Yurakucho, Chiyoda-ku, Tokyo 100-0006 Japan

SMC Ltd Announces Expansion of Sterile Fill Finish Capabilities, Unveiling State-of-the-Art Facility in North Carolina, US

26 March 2024 -- Wisconsin, US -- SMC Ltd, the worldwide contract manufacturer of single use and disposable medical devices, has today announced the acquisition of an end-to-end fill/finish facility...

Category: Manufacturing and Packing
Posted: March 26, 2024

SMC Ltd
inquiry@smcltd.com
330 SMC Drive Somerset WI 54025 U.S.A

Gilbert To Officially Open New Development and GMP Manufacturing Facility

22 March 2024 -- Nottingham, UK -- UK-based contract development and manufacturing organisation (CDMO) Upperton Pharma Solutions was joined by Oxford/AstraZeneca COVID-19 vaccine co-inventor Professor Dame Sarah Gilbert, biotech industry representatives and...

Category: BioManufacturing, Clinical Trials, Manufacturing and Packing
Posted: March 22, 2024

Upperton Pharma Solutions
contact@upperton.com
Albert Einstein Centre, Nottingham Science Park, Nottingham, UK, NG7 2TN

Epsilogen and Lonza Announce Successful Large-Scale GMP Manufacturing of MOv18, an IgE Antibody Targeting Ovarian Cancer

First time GMP manufacturing of a therapeutic IgE antibody has been achieved at scale GMP material to be used in phase 1b study in platinum-resistant ovarian cancer (PROC) patients scheduled...

Category: BioManufacturing
Posted: March 5, 2024

Epsilogen
info@epsilogen.com
Waterfront, ARC West London, Manbre Road, Hammersmith, London, W6 9RH

Kite Presents New Data for Yescarta (axicabtagene ciloleucel) CAR T-cell Therapy Highlighting Manufacturing Excellence and Cost-Effectiveness in the US

Data Highlights Industry-leading Manufacturing Success Rates for US Axicabtagene Ciloleucel Patients from Launch to Present Data Also Supports Cost-effectiveness of Axicabtagene Ciloleucel Versus Bispecific Antibodies 16 February 2024 – Stockley...

Category: BioManufacturing
Posted: February 21, 2024

Kite Pharma
2400 Broadway Santa Monica, CA 90404

Global End-to-End Solutions Partner to Life Sciences Organisations, AscellaHealth, joins Manchester Science Park

20 February 2024 -- Manchester, UK -- Global healthcare and specialty pharmacy solutions company providing innovative solutions to life sciences and biotech manufacturers, AscellaHealth, is expanding its UK presence with...

Category: Manufacturing and Packing
Posted: February 20, 2024

AscellaHealth
info@ascellahealth.com
AscellaHealth, LLC 1055 Westlakes Drive Suite 175 Berwyn, PA 19312, US

Cellular Origins, a TTP Company, appoints Peter Crossley as Chief Operating Officer

Product and technology innovator will build team to further develop and deliver Cellular Origins’ products for cell and gene therapy manufacture at scale 25 January 2024 -- Cambridge, UK --...

Category: BioManufacturing
Posted: January 25, 2024

Cellular Origins
hello@cellularorigins.com
TTP Campus Cambridge Road Melbourn SG8 6HQ

Broken String Biosciences strengthens senior leadership team to accelerate product development and commercialisation

Appointment of Vincent Smith PhD, as chief technology officer and Jessica Rich as VP of Business Development Follows Broken String’s successful $15m Series A fundraising round in September 2023 Will...

Category: Biotechnology
Posted: October 4, 2023

Broken String Biosciences
info@brokenstringbio.com
Unit AB3-04, Level 3 BioData Innovation Centre Wellcome Genome Campus Hinxton Cambridge, CB10 1DR

Broken String Biosciences Closes $15m Series A Funding Round

Funds to support further development and commercialisation of the company’s INDUCE-seq DNA break mapping technology Platform technology provides in situ off-target measurement in clinically relevant cells to accelerate the progression...

Category: Biotechnology
Posted: September 18, 2023

Broken String Biosciences
info@brokenstringbio.com
Unit AB3-04, Level 3 BioData Innovation Centre Wellcome Genome Campus Hinxton Cambridge, CB10 1DR